Derivation and validation of a prognostic model for pulmonary embolism.

RATIONALE An objective and simple prognostic model for patients with pulmonary embolism could be helpful in guiding initial intensity of treatment. OBJECTIVES To develop a clinical prediction rule that accurately classifies patients with pulmonary embolism into categories of increasing risk of mortality and other adverse medical outcomes. METHODS We randomly allocated 15,531 inpatient discharges with pulmonary embolism from 186 Pennsylvania hospitals to derivation (67%) and internal validation (33%) samples. We derived our prediction rule using logistic regression with 30-day mortality as the primary outcome, and patient demographic and clinical data routinely available at presentation as potential predictor variables. We externally validated the rule in 221 inpatients with pulmonary embolism from Switzerland and France. MEASUREMENTS We compared mortality and nonfatal adverse medical outcomes across the derivation and two validation samples. MAIN RESULTS The prediction rule is based on 11 simple patient characteristics that were independently associated with mortality and stratifies patients with pulmonary embolism into five severity classes, with 30-day mortality rates of 0-1.6% in class I, 1.7-3.5% in class II, 3.2-7.1% in class III, 4.0-11.4% in class IV, and 10.0-24.5% in class V across the derivation and validation samples. Inpatient death and nonfatal complications were <or= 1.1% among patients in class I and <or= 1.9% among patients in class II. CONCLUSIONS Our rule accurately classifies patients with pulmonary embolism into classes of increasing risk of mortality and other adverse medical outcomes. Further validation of the rule is important before its implementation as a decision aid to guide the initial management of patients with pulmonary embolism.

[1]  Gregory F Cooper,et al.  A prediction rule to identify low-risk patients with heart failure. , 2005, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[2]  G. Simonneau,et al.  A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. , 1997, The New England journal of medicine.

[3]  P. Romano,et al.  Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. , 2000, The New England journal of medicine.

[4]  M. Fine,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[5]  R. C. Bradbury,et al.  Predicted probabilities of hospital death as a measure of admission severity of illness. , 1993, Inquiry : a journal of medical care organization, provision and financing.

[6]  R. D'Agostino,et al.  Predicting mortality in nursing home residents with lower respiratory tract infection: The Missouri LRI Study. , 2001, JAMA.

[7]  Daniel Hayoz,et al.  Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. , 2004 .

[8]  J. Douketis,et al.  Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. , 1998, JAMA.

[9]  P. Cecchini,et al.  Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. , 2000, Circulation.

[10]  R. Klocke,et al.  THE AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 1994 .

[11]  J. Beer,et al.  Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients 1 , 2003, Journal of thrombosis and haemostasis : JTH.

[12]  A. Laupacis,et al.  Clinical prediction rules. A review and suggested modifications of methodological standards. , 1997, JAMA.

[13]  B. Macmahon.  The National Death Index. , 1983, American journal of public health.

[14]  Samuel Z Goldhaber,et al.  Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) , 1999, The Lancet.

[15]  E. Frye,et al.  Admission hyponatremia in the elderly , 1994, Journal of General Internal Medicine.

[16]  H. Sox,et al.  Clinical prediction rules. Applications and methodological standards. , 1985, The New England journal of medicine.

[17]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[18]  G H Guyatt,et al.  Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. , 2000, JAMA.

[19]  B E Fries,et al.  The accuracy of the National Death Index when personal identifiers other than Social Security number are used. , 1992, American journal of public health.

[20]  P. Wells,et al.  Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection. , 1998, Archives of internal medicine.

[21]  H. Büller,et al.  Prognostic Value of Echocardiographically Assessed Right Ventricular Dysfunction in Patients With Pulmonary Embolism , 2004 .

[22]  Charles Maynard,et al.  A primer and comparative review of major US mortality databases. , 2002, Annals of epidemiology.

[23]  T. Perneger,et al.  Predicting Adverse Outcome in Patients with Acute Pulmonary Embolism: A Risk Score , 2000, Thrombosis and Haemostasis.

[24]  G. Wells,et al.  A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. , 2005, Archives of internal medicine.

[25]  M. Olschewski,et al.  Importance of Cardiac Troponins I and T in Risk Stratification of Patients With Acute Pulmonary Embolism , 2002, Circulation.

[26]  M. Holzer,et al.  Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. , 2000, Archives of internal medicine.

[27]  T. Clarkson,et al.  Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. , 2003 .

[28]  W M O'Fallon,et al.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. , 1998, Archives of internal medicine.

[29]  H. Hodkinson.  Value of Admission Profile Tests for Prognosis in Elderly Patients , 1981, Journal of the American Geriatrics Society.

[30]  M. Kovacs,et al.  Outpatient Treatment of Pulmonary Embolism with Dalteparin , 2000, Thrombosis and Haemostasis.

[31]  A. Fennerty,et al.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism , 2003, Thorax.

[32]  H. Katus,et al.  Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. , 2000, Circulation.

[33]  P. Romano,et al.  Comparison of Outcomes after Hospitalization for Deep Venous Thrombosis or Pulmonary Embolism , 2002, Thrombosis and Haemostasis.

[34]  D. Parr,et al.  Early discharge and home supervision of patients with pulmonary embolism treated with low-molecular weight heparin. , 2003, European journal of internal medicine.

[35]  P. Walker,et al.  A population based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study. Anderson FA, Wheeler HB, Goldberg RJ, et al. Arch Intern Med 1991;151:933-8 , 1992 .

[36]  J. Vincent,et al.  Body temperature alterations in the critically ill , 2004, Intensive Care Medicine.

[37]  Graves Ej,et al.  National Hospital Discharge Survey , 2004 .

[38]  W. Brady,et al.  Altered mental status: evaluation and etiology in the ED. , 2002, The American journal of emergency medicine.

[39]  D. Hosmer,et al.  A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. , 1991, Archives of internal medicine.

[40]  L. Melton,et al.  Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. , 1999, Archives of internal medicine.

[41]  H. R. Guo,et al.  Hyponatremia in the emergency department. , 2000, The American journal of emergency medicine.

[42]  J. Douketis.  Prognosis in pulmonary embolism , 2001, Current opinion in pulmonary medicine.

[43]  E W Steyerberg,et al.  Clinical prediction rule for 30-day mortality in Björk-Shiley convexo-concave valve replacement. , 2003, Journal of clinical epidemiology.

[44]  W. Bargar,et al.  Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. , 1998, Archives of internal medicine.

[45]  Roslyn A Stone,et al.  A prediction rule to identify low-risk patients with pulmonary embolism. , 2006, Archives of internal medicine.

[46]  A. Kitabchi,et al.  Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. , 2002, The Journal of clinical endocrinology and metabolism.

[47]  A. Alavi,et al.  The clinical course of pulmonary embolism. , 1992, The New England journal of medicine.

[48]  Kenneth J. Smith,et al.  Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism. , 2005, Chest.

[49]  Arl Medford,et al.  British Thoracic Society , 2004 .

[50]  L. Kozak,et al.  National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data. , 2005, Vital and health statistics. Series 13, Data from the National Health Survey.

[51]  J. Cornuz,et al.  Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome , 2004, Thrombosis and Haemostasis.

[52]  Jesse A. Berlin,et al.  Assessing the Generalizability of Prognostic Information , 1999 .